The Research Applications Directorate

The ICM's Research Applications Department steers the Institute's intellectual property strategy and partnerships with industry, in compliance with the Carnot charter.  In this context, it ensures that its approach is guided by operational efficiency in order to serve the research and innovation needs of companies.
Open / close summary

Our team is dedicated to connecting and fostering interaction between the institute’s academic researchers and those in industry, both in neuroscience and in broader applications.

 

A dynamic team of about ten people is in charge of four essential missions:

  • Detecting promising projects directly with researchers, raising awareness of patent filing and accompanying them through the filing process.
  • Patent licensing to young companies and large groups.
  • Assistance and advice to spinoffs of the Institut du Cerveau – ICM and young startups collaborating with the Institute’s academic teams, through the iPEPS business incubator.
  • Designing, setting up and monitoring ambitious industrial alliances to accelerate the arrival of products on the market – i.e. patient care.

 

Are you currently looking to license? We hold patents in the following areas:

  • Glioma diagnosis
  • Parkinson’s disease
  • Neurodegenerative diseases
  • Epilepsy
  • Sleep and memory
  • Dopamineragil-related disorders
  • Cerebellar disorders
  • Hungtingon’s disease

DIRECTION

Alexis Génin heads the Research & Technology Development office at Institut du Cerveau, since 2010. He holds a PhD in neurosciences. After a research assignment in Asia and collaborative programs with the pharmaceutical industry, he took responsibility of international business development operations for a Paris-based medtech & diagnostic company. Alexis participated to the establishment of INSERM-Transfert, a spin-off company from INSERM, in charge of Tech transfer, before joining the Institut du Cerveau at its start.

Email

 

OFFICE MANAGEMENT 

Valérie Fonteny is Office Manager, in charge of the administrative management of partnerships and patents, and of logistical and organizational issues. She holds a tourism technician’s certificate (national interpreter-guide) and an art history postgraduate diploma. She worked at the National Cancer Institute as an executive assistant, then as a project manager with the director of research. Previously, she worked at Orphanet, the portal of rare diseases and orphan drugs.

Email

 

 

 

BIOTECH / DRUG DEVELOPMENT

Athanasia Liabotis is in charge of preclinical projects development. She holds a PhD in cell biology and physiology from Sorbonne University, which she achieved at the Collège de France in Paris. After a Specialized Master in pharmaceutical and biotechnology management at ESCP Europe Business School, she joined the Roche Institute as a scientific project manager.

Email

 

 

 

 

 

 

Etienne Blanc is in the charge of the detection and the development of preclinical projects. He also assists the startups incubated at the institute in their interactions with the ICM research teams. Etienne holds a bachelor’s degree in Biomedical Sciences, a master’s degree in Biotechnologies and a specialized master’s degree in Innovation & Entrepreneurship from Paris Sciences et Lettres University. He has worked in both the public and private sector in relations with Biotech startups.

Email

 

 

 

 

Paola Ramirez is a research engineer in drug screening. Paola is in charge of preclinical testing of new drug candidates developed by research teams at Institut du Cerveau and a variety of medicinal chemists She has an engineering degree on ‘’integrative pathophysiology’’ from the Ecole Pratique des Hautes Etudes. She worked as an engineer at ICM, on a team interesting on therapetic drug development for the treatment of Parkinson’s disease.

 

Email

 

 

 

 

MEDTECH / LIVING LAB

Fanny Audibert is the Medtech development and Living Lab Manager. Before taking on the role of Medtech Development Manager, she was in charge of Biotech business development and partnership at the Institute. Prior to joining the Institute, Fanny trained in Business Development with Theranexus; she also worked at Bpifrance le Hub in the support of startups. She holds a Master’s degree in Bio-Engineering and Innovation in Neurosciences from ESPCI and a Specialised Master in Biopharmaceutical Management from ESCP Europe Business School.

 

Email

 

 

 

Caroline Ronzeau is the Business Designer of the Care Lab. She has a dual background in business and design following her studies in business school at ISG, her master’s degree in digital and design at Audencia, and her experience in the management and design of innovative projects in the insurance sector. She is now in charge of the startups’ needs on the UX/UI part, MVP building and usability tests, as well as the business analysis of projects led by caregivers or researchers.

 

Email

 

 

 

Pierre Tissier is a prototyping engineer at the Institut du Cerveau. He designs and produces technologies for research purposes and for patient care. He also provides access to the latest prototyping technologies (3D printers, laser cutting machine…) to researchers and industry partners. Pierre holds a Master degree in robotic engineering from the mechanical engineering school SupMeca.

 

Email

 

 

 

 

 

Sarah Benessiano is in charge of project development at the Institut du Cerveau’s LivingLab. She assists healthcare professionals in the definition, implementation and development of their innovation projects, with the support of design and engineering students. She holds a Master’s degree in Product and UX Design from Strate school of design and an engineering bachelor from the IUT of Cachan.

 

Email

 

Julie Sauzin is a designer in charge of the “Parkcare” program in partnership with the start-up Diampark. This program aims to create and develop solutions to improve the patient journey for patients suffering from Parkinson’s disease. She holds a Master’s degree in Service and UX Design from Strate école de Design, as well as an entrepreneurship degree from ESCP Europe.

 

 

Email

 

 

 

 

iPEPS INCUBATOR

Camille DORRA is Medtech and Artificial Intelligence manager for the iPEPS incubator. Her missions aim at supporting the Startups of the “Chevaleret” campus through several programs. She has a dual background in biology and entrepreneurship. Camille has been working for more than 4 years with startups in the health sector: after an experience in a financial consulting firm, she joined a health incubator and supported more than 40 startups in the sector.

 

Email

 

 

 

 

Louise Remigereau is in charge of logistical and organizational aspects of the iPEPS incubator. She holds a bachelor in communication and a master’s degree in event management. She has always worked in connection with small- and medium-size companies.

 

Email

 

 

 

 

 

 

Paul Sarret is Start-up Support Officer at the iPEPS. Before taking on the role of SU Support Officer, he was working as an Health Business Development at Erganeo. Prior to joining the Institute, Paul trained in Business Development and Health Business Analyst with Erganeo; he also worked at Regeneus, an Australian Biotech Start-up. He holds a Master’s degree in Biotherapy from Paris Saclay University and a Specialised Master in Strategy and International Business Development from EM Lyon Business School and Centrale Supelec.

 

Email

 

 

Alkis Manoussakis is in charge of projects and partnerships for large groups within the institute. Before that he has worked at Digital Pharma Lab as Project Start-up Manager, specializing in innovation and digital health. Alkis is a pharmacist by training with a double degree in business school.

 

Email

 

 

 

 

ENTREPRENEURS IN RESIDENCE & MENTORS

Damien Salauze is entrepreneur in residence at IPEPS-Institut du Cerveau. He holds a PharmD, PhD, as well as an MBA from INSEAD. He first worked at Rhône-Poulenc / Aventis in drug-development position and marketing positions, and then joined the venture-capital firm Auriga Partners. He there became CEO of 2 start-up companies: Novagali Pharma then Sepal Pharma. He also headed the Office of technology Transfer at Institut Curie. Damien serves as equity manager for Institut du Cerveau (in addition to heading of the FINDMED consortium, coordinated by Institut du Cerveau).


Email

 

 

Ségolène Aymé is rare disease expert in residence at Institut du Cerveau, as Emeritus director of Research at INSERM. She was a medical geneticist and epidemiologist. She founded Orphanet and the Orphanet Journal of Rare Diseases. She held several international positions in the field of rare diseases and orphan drugs research and policy. Ségolène contributes to the development of the Institut du Cerveau activities in favor of the rare neurological diseases.

Email